GPX4 and gastric cancer: At this time, we determined that POLE2 knockdown inhibited, while POLE2 overexpression activated the NRF2/GPX4 pathway in human gastric cancer cells, and that either NRF2 or GPX4 silence blocked POLE2 overexpression‐mediated inductions of cell proliferation, migration, invasion and inhibition of ferroptosis.